European Commission

Person
Mentions
2
Relationships
0
Events
4
Documents
1
Also known as:
President of the European Commission

Relationship Network

Loading... nodes
Interactive Network: Click nodes or edges to highlight connections and view details with action buttons. Drag nodes to reposition. Node size indicates connection count. Line color shows relationship strength: red (8-10), orange (6-7), yellow (4-5), gray (weak). Use legend and help buttons in the graph for more guidance.

Event Timeline

Interactive Timeline: Hover over events to see details. Events are arranged chronologically and alternate between top and bottom for better visibility.
No relationships found for this entity.
Date Event Type Description Location Actions
2019-10-01 N/A European Commission expected to release a draft act to authorize CBD (future tense in document). EU View
2017-05-01 N/A UN-sponsored donors conference on Yemen Geneva View
2015-09-01 N/A The European Commission is expected to make a final decision on the Marketing Authorization Appli... European Union View
2015-09-01 N/A Expected final decision by European Commission on Marketing Authorization Application European Union View

HOUSE_OVERSIGHT_023567.jpg

This document is a printout of a Financial Times article dated November 27, 2015, written by John Dizard. The article discusses the negative economic impacts of quantitative easing by the European Central Bank, arguing it is leading to the insolvency of life insurers and pension plans in Europe. The printout is dated July 22, 2016, and bears a House Oversight Bates stamp.

News article / web printout
2025-11-19
Total Received
$0.00
0 transactions
Total Paid
$144,000,000.00
1 transactions
Net Flow
-$144,000,000.00
1 total transactions
Date Type From To Amount Description Actions
N/A Paid European Commission Research/Therapy ... $144,000,000.00 To develop 200 new therapies View
As Sender
0
As Recipient
0
Total
0
No communications found for this entity. Entity linking may need to be improved.

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein entity